RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$4.80
0.05 (1.05%)
▲
5d:
-2.83%
30d:
-12.09%
90d:
-35.31%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RLMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RLMD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $4.80, which is considered oversold relative to its 30-day fair value range of $4.86 to $6.08.
Technical Outlook: Technically, RLMD is in a strong downtrend. Immediate support is located at $4.35, while resistance sits at $5.58.
Market Sentiment: RLMD scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.67 (+163.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RLMD is in a strong downtrend. Immediate support is located at $4.35, while resistance sits at $5.58.
Market Sentiment: RLMD scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.67 (+163.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.86 -
$6.08
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 163.9% below Wall St target ($12.67)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.86 -
$6.08
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.35
Resistance Level
$5.58
Current Trend
Strong Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.57
Wall Street Target
$12.67
(+163.9%)
Share & Embed Analysis
Last updated: August 16, 2026 2:57 AM ET
Data refreshes hourly during market hours. Next update: 3:57 AM
Data refreshes hourly during market hours. Next update: 3:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 66 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 37 SELL |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 41 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$106 | 50 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$140 | 67 BUY |
